Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Total Debt (2020 - 2021)

Historic Total Debt for Whitehawk Therapeutics (WHWK) over the last 1 years, with Q4 2021 value amounting to $6.0 million.

  • Whitehawk Therapeutics' Total Debt changed N/A to $6.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was $6.0 million, marking a year-over-year change of. This contributed to the annual value of $6.0 million for FY2021, which is N/A changed from last year.
  • Per Whitehawk Therapeutics' latest filing, its Total Debt stood at $6.0 million for Q4 2021.
  • Whitehawk Therapeutics' 5-year Total Debt high stood at $6.0 million for Q4 2021, and its period low was $5.8 million during Q3 2021.